SYDNEY, Feb 16 (Reuters) - Australia's medical regulator said on Tuesday it had granted provisional approval for the COVID-19 vaccine developed by AstraZeneca (NASDAQ:AZN) AZN.L , making it the second vaccine to get regulatory approval in Australia.
The regulator last month approved the Pfizer-BioNTech COVID-19 vaccine for use and inoculations for its 25 million population will begin from Feb. 22.